11 billion compounds available for your research at Chemspace

webinar

Mon, 28 Oct 2019, 16:00 CET (Berlin)

Dr. Yurii S. Moroz, CEO of Chemspace, Riga, Latvia

11 billion compounds available for your research at Chemspace

Chemspace just renewed its claim to be the largest online resource for small molecules. Including the REAL Space with more than 11 billion virtual product molecules provided on demand by Enamine, Chemspace again outnumbers all other small molecule resources by orders of magnitude. The success of your project depends on choosing the right source of molecules and medicinal chemistry expertise. At Chemspace, we understand your needs and guarantee molecules delivery in the required amount with high purity and always on time. Close collaboration with our respectful suppliers including Enamine, FCH group, and UORSY, among others, allows us to achieve this goal. In this webinar you’ll learn what Chemspace offers, how we work and why Chemspace stands out as the premier provider of high-quality drug discovery solutions.

Current news

Tool of the Month - infiniSee 7.1 'Arke'
May 27, 2026 09:44 CEST
Navigate Chemical Space with infiniSee 7.1 ‘Arke’ The ultimate platform for exploring ultra-large Chemical Spaces is taking a huge leap forward. Combining our Tool of the Month series with an exciting software release, we are happy to present infiniSee 7.1 ‘Arke’. Allowing you to search deeper and evaluate compounds more...
Read on
category
Software
infiniSee 7.1 'Arke' Is Now Available
May 26, 2026 16:49 CEST
We are delighted to introduce infiniSee 7.1 ‘Arke’, another helpful step forward in making the exploration of vast Chemical Spaces faster, clearer, and more intuitive. With this update, we focused on two central goals: helping users move through ultra-large Chemical Spaces more efficiently and making compound assessment more visual and...
Read on
VAST™ Space by XtalPi - Access now with our tools
May 21, 2026 10:42 CEST
The VAST™ Space brings an actionable, navigable universe of 4.66 billion accessible, drug-like products directly into your workflow. Created by XtalPi, this collection was built from 40+ validated reaction protocols and 58,000 in-stock building blocks. By pairing automated synthesis with proprietary feasibility models, it delivers a highly reliable and innovative...
Read on